{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:20:29Z","timestamp":1773271229419,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Axial spondyloarthritis (axSpA) is a chronic, inflammatory, immune-mediated disease characterized by inflammation of the axial skeleton, peripheral joints, and entheses. Patients with axSpA often experience a long diagnostic delay, and if left untreated, axSpA can lead to a substantial disease burden and permanent disability. In the US, axSpA is more commonly reported in White individuals than non-White individuals because of its strong association with the HLA-B27 allele, which is more common in White populations and certain Native American tribes. Underrecognition of the disease in non-White patient groups may contribute to underreporting of prevalence, diagnostic delay, undertreatment, and unnecessary disease burden in these patient populations. The goal of this review is to increase awareness and educate healthcare professionals on axSpA in non-White patients by reviewing epidemiology, diagnostic delay, genetic aspects, disease presentation, and treatment disparities among non-White patient populations in the US to promote timely recognition and treatment of axSpA in these patients.<\/jats:p>","DOI":"10.1007\/s10067-026-07974-7","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:14:31Z","timestamp":1770452071000},"page":"2127-2136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Race as a determinant of clinical characteristics, treatments, and outcomes of axial spondyloarthritis in the United States"],"prefix":"10.1007","volume":"45","author":[{"given":"Catherine","family":"Bakewell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6043-7277","authenticated-orcid":false,"given":"Grace C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"5","key":"7974_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.2024.20917","volume":"333","author":"M Bittar","year":"2025","unstructured":"Bittar M, Deodhar A (2025) Axial spondyloarthritis: a review. JAMA 333(5):408\u2013420. https:\/\/doi.org\/10.1001\/jama.2024.20917","journal-title":"JAMA"},{"issue":"12","key":"7974_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2017.49","volume":"6","author":"Z Li","year":"2017","unstructured":"Li Z, Brown MA (2017) Progress of genome-wide association studies of ankylosing spondylitis. Clin Transl Immunol 6(12):e163. https:\/\/doi.org\/10.1038\/cti.2017.49","journal-title":"Clin Transl Immunol"},{"issue":"7","key":"7974_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/acr2.11555","volume":"5","author":"A Deodhar","year":"2023","unstructured":"Deodhar A, Gill T, Magrey M (2023) Human leukocyte antigen B27-negative axial spondyloarthritis: what do we know? ACR Open Rheumatol 5(7):333\u2013344. https:\/\/doi.org\/10.1002\/acr2.11555","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"7974_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/maj.0b013e318294457f","volume":"345","author":"JD Reveille","year":"2013","unstructured":"Reveille JD, Weisman MH (2013) The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 345(6):431\u2013436. https:\/\/doi.org\/10.1097\/maj.0b013e318294457f","journal-title":"Am J Med Sci"},{"key":"7974_CR5","doi-asserted-by":"publisher","unstructured":"Rudwaleit M, Landew\u00e9 R, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68(6):770\u2013776. https:\/\/doi.org\/10.1136\/ard.2009.108217","DOI":"10.1136\/ard.2009.108217"},{"issue":"Suppl4","key":"7974_CR6","doi-asserted-by":"publisher","first-page":"iv18","DOI":"10.1093\/rheumatology\/keaa422","volume":"59","author":"X Michelena","year":"2020","unstructured":"Michelena X, L\u00f3pez-Medina C, Marzo-Ortega H (2020) Non-radiographic versus radiographic axSpA: what\u2019s in a name? Rheumatology (Oxford) 59(Suppl4):iv18-24. https:\/\/doi.org\/10.1093\/rheumatology\/keaa422","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7974_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mayocp.2021.08.007","volume":"97","author":"S Schwartzman","year":"2022","unstructured":"Schwartzman S, Ruderman EM (2022) A road map of the axial spondyloarthritis continuum. Mayo Clin Proc 97(1):134\u2013145. https:\/\/doi.org\/10.1016\/j.mayocp.2021.08.007","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"7974_CR8","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/art.39612","volume":"68","author":"A Deodhar","year":"2016","unstructured":"Deodhar A, Mease PJ, Reveille JD et al (2016) Frequency of axial spondyloarthritis diagnosis among patients seen by US rheumatologists for evaluation of chronic back pain. Arthritis Rheumatol 68(7):1669\u20131676. https:\/\/doi.org\/10.1002\/art.39612","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"7974_CR9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/rheumatology\/keaa807","volume":"60","author":"SS Zhao","year":"2021","unstructured":"Zhao SS, Pittam B, Harrison NL, Ahmed AE, Goodson NJ, Hughes DM (2021) Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 60(4):1620\u20131628. https:\/\/doi.org\/10.1093\/rheumatology\/keaa807","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7974_CR10","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/rheumatology\/keae521","volume":"64","author":"D Poddubnyy","year":"2025","unstructured":"Poddubnyy D, Garrido-Cumbrera M, Sommerfleck F et al (2025) Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factors. Rheumatology (Oxford) 64(4):1873\u20131879. https:\/\/doi.org\/10.1093\/rheumatology\/keae521","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7974_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40744-020-00194-8","volume":"7","author":"E Yi","year":"2020","unstructured":"Yi E, Ahuja A, Rajput T, George AT, Park Y (2020) Clinical, economic, and humanistic burden associated with delayed diagnosis of axial spondyloarthritis: a systematic review. Rheumatol Ther 7(1):65\u201387. https:\/\/doi.org\/10.1007\/s40744-020-00194-8","journal-title":"Rheumatol Ther"},{"issue":"8","key":"7974_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s10067-014-2768-y","volume":"34","author":"MR Seo","year":"2015","unstructured":"Seo MR, Baek HL, Yoon HH et al (2015) Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis. Clin Rheumatol 34(8):1397\u20131405. https:\/\/doi.org\/10.1007\/s10067-014-2768-y","journal-title":"Clin Rheumatol"},{"key":"7974_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151996","volume":"54","author":"A Ho","year":"2022","unstructured":"Ho A, Younis I, Le QA (2022) Impact of biologics on health-related quality of life in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials. Semin Arthritis Rheum 54:151996. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151996","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"7974_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.5811\/westjem.58408","volume":"24","author":"WL Macias-Konstantopoulos","year":"2023","unstructured":"Macias-Konstantopoulos WL, Collins KA, Diaz R et al (2023) Race, healthcare, and health disparities: a critical review and recommendations for advancing health equity. West J Emerg Med 24(5):906\u2013918. https:\/\/doi.org\/10.5811\/westjem.58408","journal-title":"West J Emerg Med"},{"issue":"5","key":"7974_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.semarthrit.2016.10.010","volume":"46","author":"C McDougall","year":"2017","unstructured":"McDougall C, Hurd K, Barnabe C (2017) Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. Semin Arthritis Rheum 46(5):675\u2013686. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.10.010","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"7974_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00002281-199807000-00007","volume":"10","author":"B Walsh","year":"1998","unstructured":"Walsh B, Yocum DE, Khan MA (1998) Arthritis and HLA-B27 in native North American tribes. Curr Opin Rheumatol 10(4):319\u2013325. https:\/\/doi.org\/10.1097\/00002281-199807000-00007","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"7974_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s40744-021-00370-4","volume":"8","author":"A Ogdie","year":"2021","unstructured":"Ogdie A, Matthias W, Thielen RJ, Chin D, Saffore CD (2021) Racial differences in prevalence and treatment for psoriatic arthritis and ankylosing spondylitis by insurance coverage in the USA. Rheumatol Ther 8(4):1725\u20131739. https:\/\/doi.org\/10.1007\/s40744-021-00370-4","journal-title":"Rheumatol Ther"},{"issue":"6","key":"7974_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/acr.21621","volume":"64","author":"JD Reveille","year":"2012","unstructured":"Reveille JD, Witter JP, Weisman MH (2012) Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res (Hoboken) 64(6):905\u2013910. https:\/\/doi.org\/10.1002\/acr.21621","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"7974_CR19","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/art.33503","volume":"64","author":"JD Reveille","year":"2012","unstructured":"Reveille JD, Hirsch R, Dillon CF, Carroll MD, Weisman MH (2012) The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. Arthritis Rheum 64(5):1407\u20131411. https:\/\/doi.org\/10.1002\/art.33503","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"7974_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000053","volume":"1","author":"X Baraliakos","year":"2015","unstructured":"Baraliakos X, Braun J (2015) Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD Open 1(Suppl 1):e000053. https:\/\/doi.org\/10.1136\/rmdopen-2015-000053","journal-title":"RMD Open"},{"issue":"12","key":"7974_CR21","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3899\/jrheum.130588","volume":"40","author":"D Wallis","year":"2013","unstructured":"Wallis D, Haroon N, Ayearst R, Carty A, Inman RD (2013) Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? J Rheumatol 40(12):2038\u20132041. https:\/\/doi.org\/10.3899\/jrheum.130588","journal-title":"J Rheumatol"},{"issue":"1","key":"7974_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun J, Bollow M, Remlinger G et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41(1):58\u201367. https:\/\/doi.org\/10.1002\/1529-0131(199801)41:1%3c58::AID-ART8%3e3.0.CO;2-G","journal-title":"Arthritis Rheum"},{"key":"7974_CR23","doi-asserted-by":"publisher","unstructured":"van der Linden SM, Valkenburg HA, de Jongh BM, Cats A (1994) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27(3):241\u2013249. https:\/\/doi.org\/10.1002\/art.1780270301","DOI":"10.1002\/art.1780270301"},{"issue":"7","key":"7974_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes A, Hadler J, Pointon JP et al (2013) Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 45(7):730\u2013738. https:\/\/doi.org\/10.1038\/ng.2667","journal-title":"Nat Genet"},{"issue":"2","key":"7974_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ng.513","volume":"42","author":"JD Reveille","year":"2010","unstructured":"Reveille JD, Sims AM, Danoy P et al (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42(2):123\u2013127. https:\/\/doi.org\/10.1038\/ng.513","journal-title":"Nat Genet"},{"issue":"1","key":"7974_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/annrheumdis-2018-213779","volume":"78","author":"JD Reveille","year":"2019","unstructured":"Reveille JD, Zhou X, Lee M et al (2019) HLA class I and II alleles in susceptibility to ankylosing spondylitis. Ann Rheum Dis 78(1):66\u201373. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213779","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"7974_CR27","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"PR Burton","year":"2007","unstructured":"Burton PR, Clayton DG, Cardon LR et al (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39(11):1329\u20131337. https:\/\/doi.org\/10.1038\/ng.2007.17","journal-title":"Nat Genet"},{"issue":"1","key":"7974_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11769","volume":"7","author":"K Kommineni","year":"2025","unstructured":"Kommineni K, Abutineh I, Chapman C, Pattanaik D, Bittar M (2025) Axial spondyloarthritis in Black Americans: an observational study from five centers in Shelby County, Tennessee. ACR Open Rheumatol 7(1):e11769. https:\/\/doi.org\/10.1002\/acr2.11769","journal-title":"ACR Open Rheumatol"},{"issue":"4","key":"7974_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0198-8859(86)90059-5","volume":"16","author":"JA Hansen","year":"1986","unstructured":"Hansen JA, Lanier AP, Nisperos B, Mickelson E, Dahlberg S (1986) The HLA system in Inupiat and Central Yupik Alaskan Eskimos. Hum Immunol 16(4):315\u2013328. https:\/\/doi.org\/10.1016\/0198-8859(86)90059-5","journal-title":"Hum Immunol"},{"issue":"1","key":"7974_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0198-8859(81)90045-8","volume":"3","author":"TT Kuberski","year":"1981","unstructured":"Kuberski TT, Morse HG, Rate RG, Bonnell MD, Wood JG, Bennett PH (1981) A hospital-based survey of radiological sacroiliitis and HLA-B27 and Cw2 in Navajo and Hopi Indians. Hum Immunol 3(1):77\u201383. https:\/\/doi.org\/10.1016\/0198-8859(81)90045-8","journal-title":"Hum Immunol"},{"issue":"6","key":"7974_CR31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3899\/jrheum.181019","volume":"47","author":"DK Singh","year":"2020","unstructured":"Singh DK, Magrey MN (2020) Racial differences in clinical features and comorbidities in ankylosing spondylitis in the United States. J Rheumatol 47(6):835\u2013838. https:\/\/doi.org\/10.3899\/jrheum.181019","journal-title":"J Rheumatol"},{"issue":"10","key":"7974_CR32","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s10067-017-3767-6","volume":"36","author":"F Jamalyaria","year":"2017","unstructured":"Jamalyaria F, Ward MM, Assassi S et al (2017) Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups. Clin Rheumatol 36(10):2359\u20132364. https:\/\/doi.org\/10.1007\/s10067-017-3767-6","journal-title":"Clin Rheumatol"},{"issue":"2","key":"7974_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jbspin.2006.11.003","volume":"74","author":"J Freeston","year":"2007","unstructured":"Freeston J, Barkham N, Hensor E, Emery P, Fraser A (2007) Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies. Joint Bone Spine 74(2):140\u2013143. https:\/\/doi.org\/10.1016\/j.jbspin.2006.11.003","journal-title":"Joint Bone Spine"},{"issue":"1","key":"7974_CR34","first-page":"78","volume":"7","author":"C Popescu","year":"2014","unstructured":"Popescu C, Trandafir M, B\u0103dic\u0103 A, Morar F, Prede\u0163eanu D (2014) Ankylosing spondylitis functional and activity indices in clinical practice. J Med Life 7(1):78\u201383","journal-title":"J Med Life"},{"issue":"11","key":"7974_CR35","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1136\/ard.2011.152975","volume":"70","author":"HY Chung","year":"2011","unstructured":"Chung HY, Machado P, van der Heijde D, D\u2019Agostino MA, Dougados M (2011) HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann Rheum Dis 70(11):1930\u20131936. https:\/\/doi.org\/10.1136\/ard.2011.152975","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7974_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91829-5","volume":"11","author":"JT Rosenbaum","year":"2021","unstructured":"Rosenbaum JT, Weisman MH, Hamilton H et al (2021) HLA-B27 is associated with reduced disease activity in axial spondyloarthritis. Sci Rep 11(1):12331. https:\/\/doi.org\/10.1038\/s41598-021-91829-5","journal-title":"Sci Rep"},{"issue":"5","key":"7974_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jbspin.2020.03.012","volume":"87","author":"M Ar\u00e9valo","year":"2020","unstructured":"Ar\u00e9valo M, L\u00f3pez-Medina C, Moreno Martinez-Losa M et al (2020) Role of HLA-B27 in the comorbidities observed in axial spondyloarthritis: data from COMOSPA. Joint Bone Spine 87(5):445\u2013448. https:\/\/doi.org\/10.1016\/j.jbspin.2020.03.012","journal-title":"Joint Bone Spine"},{"issue":"4","key":"7974_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.semarthrit.2020.05.005","volume":"50","author":"GC Wright","year":"2020","unstructured":"Wright GC, Kaine J, Deodhar A (2020) Understanding differences between men and women with axial spondyloarthritis. Semin Arthritis Rheum 50(4):687\u2013694. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.005","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"7974_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/art.1780210506","volume":"21","author":"MA Khan","year":"1978","unstructured":"Khan MA, Kushner I, Braun WE (1978) A subgroup of ankylosing spondylitis associated with HLA-B7 in American blacks. Arthritis Rheum 21(5):528\u2013530. https:\/\/doi.org\/10.1002\/art.1780210506","journal-title":"Arthritis Rheum"},{"issue":"8","key":"7974_CR40","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1136\/annrheumdis-2013-203352","volume":"73","author":"X Zhou","year":"2014","unstructured":"Zhou X, Wang J, Zou H et al (2014) MICA, a gene contributing strong susceptibility to ankylosing spondylitis. Ann Rheum Dis 73(8):1552\u20131557. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203352","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7974_CR41","first-page":"126","volume":"12","author":"JT Gran","year":"1985","unstructured":"Gran JT, Ostensen M, Husby G (1985) A clinical comparison between males and females with ankylosing spondylitis. J Rheumatol 12(1):126\u2013129","journal-title":"J Rheumatol"},{"issue":"11","key":"7974_CR42","first-page":"1900","volume":"20","author":"LG Kennedy","year":"1993","unstructured":"Kennedy LG, Will R, Calin A (1993) Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset. J Rheumatol 20(11):1900\u20131904","journal-title":"J Rheumatol"},{"issue":"4","key":"7974_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7812\/TPP\/15-151","volume":"20","author":"JR Curtis","year":"2016","unstructured":"Curtis JR, Harrold LR, Asgari MM et al (2016) Diagnostic prevalence of ankylosing spondylitis using computerized health care data, 1996 to 2009: underrecognition in a US health care setting. Perm J 20(4):4\u201310. https:\/\/doi.org\/10.7812\/TPP\/15-151","journal-title":"Perm J"},{"issue":"2","key":"7974_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3899\/jrheum.160825","volume":"44","author":"V Jovani","year":"2017","unstructured":"Jovani V, Blasco-Blasco M, Ruiz-Cantero MT, Pascual E (2017) Understanding how the diagnostic delay of spondyloarthritis differs between women and men: systematic review and metaanalysis. J Rheumatol 44(2):174\u2013183. https:\/\/doi.org\/10.3899\/jrheum.160825","journal-title":"J Rheumatol"},{"issue":"4","key":"7974_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3899\/jrheum.2024-0574","volume":"52","author":"R Ferrandiz-Espadin","year":"2025","unstructured":"Ferrandiz-Espadin R, Rabasa G, Gasman S et al (2025) Disparities in time to diagnosis of radiographic axial spondyloarthritis. J Rheumatol 52(4):344\u2013351. https:\/\/doi.org\/10.3899\/jrheum.2024-0574","journal-title":"J Rheumatol"},{"issue":"1","key":"7974_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5606\/ArchRheumatol.2016.5562","volume":"31","author":"S Fallahi","year":"2015","unstructured":"Fallahi S, Jamshidi AR (2015) Diagnostic delay in ankylosing spondylitis: related factors and prognostic outcomes. Arch Rheumatol 31(1):24\u201330. https:\/\/doi.org\/10.5606\/ArchRheumatol.2016.5562","journal-title":"Arch Rheumatol"},{"key":"7974_CR47","doi-asserted-by":"publisher","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61\u201366. https:\/\/doi.org\/10.1007\/s00296-002-0237-4","DOI":"10.1007\/s00296-002-0237-4"},{"key":"7974_CR48","unstructured":"Centers for Disease Control and Prevention (2024) National Diabetes Statistics Report. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html. Accessed 19 Nov 2025"},{"key":"7974_CR49","unstructured":"National Center for Health Statistics (2019) Racial and Ethnic Disparities in Heart Disease. https:\/\/www.cdc.gov\/nchs\/hus\/spotlight\/HeartDiseaseSpotlight_2019_0404.pdf. Accessed 19 Nov 2025"},{"key":"7974_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608134","volume":"11","author":"D Wakefield","year":"2020","unstructured":"Wakefield D, Clarke D, McCluskey P (2020) Recent developments in HLA B27 anterior uveitis. Front Immunol 11:608134. https:\/\/doi.org\/10.3389\/fimmu.2020.608134","journal-title":"Front Immunol"},{"issue":"2","key":"7974_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40744-018-0124-4","volume":"5","author":"JA Walsh","year":"2018","unstructured":"Walsh JA, Song X, Kim G, Park Y (2018) Healthcare utilization and direct costs in patients with ankylosing spondylitis using a large US administrative claims database. Rheumatol Ther 5(2):463\u2013474. https:\/\/doi.org\/10.1007\/s40744-018-0124-4","journal-title":"Rheumatol Ther"},{"key":"7974_CR52","unstructured":"US Census Bureau (2022) Health insurance coverage by race and Hispanic origin: 2021. https:\/\/www.census.gov\/library\/publications\/2022\/acs\/acsbr-012.html. Accessed 24 July 2025."},{"key":"7974_CR53","unstructured":"Centers for Medicare & Medicaid Services (2022) Race and ethnicity of the national Medicaid and CHIP population in 2020. https:\/\/www.medicaid.gov\/sites\/default\/files\/2023-08\/2020-race-etncity-data-brf.pdf. Accessed 25 May 2025"},{"issue":"Suppl 3","key":"7974_CR54","doi-asserted-by":"publisher","first-page":"S517","DOI":"10.2105\/AJPH.2015.302668","volume":"105","author":"X Han","year":"2015","unstructured":"Han X, Call KT, Pintor JK, Alarcon-Espinoza G, Simon AB (2015) Reports of insurance-based discrimination in health care and its association with access to care. Am J Public Health 105(Suppl 3):S517-525. https:\/\/doi.org\/10.2105\/AJPH.2015.302668","journal-title":"Am J Public Health"},{"key":"7974_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152436","volume":"66","author":"JA Walsh","year":"2024","unstructured":"Walsh JA, Pei S, Alexander S et al (2024) Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: an observational cohort study in United States veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Semin Arthritis Rheum 66:152436. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152436","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"7974_CR56","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1186\/s12889-022-13122-y","volume":"22","author":"S Hamed","year":"2022","unstructured":"Hamed S, Bradby H, Ahlberg BM, Thapar-Bj\u00f6rkert S (2022) Racism in healthcare: a scoping review. BMC Public Health 22(1):988. https:\/\/doi.org\/10.1186\/s12889-022-13122-y","journal-title":"BMC Public Health"},{"issue":"1","key":"7974_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1370\/afm.2632","volume":"19","author":"M Bazargan","year":"2021","unstructured":"Bazargan M, Cobb S, Assari S (2021) Discrimination and medical mistrust in a racially and ethnically diverse sample of California adults. Ann Fam Med 19(1):4\u201315. https:\/\/doi.org\/10.1370\/afm.2632","journal-title":"Ann Fam Med"},{"issue":"9","key":"7974_CR58","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.2333","volume":"2","author":"DP Ly","year":"2021","unstructured":"Ly DP (2021) Association of patient race and ethnicity with differences in opioid prescribing by primary care physicians for older adults with new low back pain. JAMA Health Forum 2(9):e212333. https:\/\/doi.org\/10.1001\/jamahealthforum.2021.2333","journal-title":"JAMA Health Forum"},{"issue":"2","key":"7974_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/pm\/pny074","volume":"20","author":"DP Ly","year":"2019","unstructured":"Ly DP (2019) Racial and ethnic disparities in the evaluation and management of pain in the outpatient setting, 2006\u20132015. Pain Med 20(2):223\u2013232. https:\/\/doi.org\/10.1093\/pm\/pny074","journal-title":"Pain Med"},{"issue":"14","key":"7974_CR60","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/BRS.0000000000002499","volume":"43","author":"CJ Milani","year":"2018","unstructured":"Milani CJ, Rundell SD, Jarvik JG et al (2018) Associations of race and ethnicity with patient-reported outcomes and health care utilization among older adults initiating a new episode of care for back pain. Spine (Phila Pa 1976) 43(14):1007\u20131017. https:\/\/doi.org\/10.1097\/BRS.0000000000002499","journal-title":"Spine (Phila Pa 1976)"},{"key":"7974_CR61","doi-asserted-by":"publisher","unstructured":"Hutchins TA, Peckham M, Shah LM et al (2021) ACR Appropriateness Criteria\u00ae low back pain: 2021 update. J Am Coll Radiol 18(11S):S361\u2013S379. https:\/\/doi.org\/10.1016\/j.jacr.2021.08.002","DOI":"10.1016\/j.jacr.2021.08.002"},{"issue":"10","key":"7974_CR62","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS et al (2019) 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol 71(10):1599\u20131613. https:\/\/doi.org\/10.1002\/art.41042","journal-title":"Arthritis Rheumatol"},{"issue":"11S","key":"7974_CR63","doi-asserted-by":"publisher","first-page":"S340","DOI":"10.1016\/j.jacr.2021.08.003","volume":"18","author":"GJ Czuczman","year":"2021","unstructured":"Czuczman GJ, Mandell JC, Wessell DE et al (2021) ACR Appropriateness Criteria\u00ae inflammatory back pain: known or suspected axial spondyloarthritis: 2021 update. J Am Coll Radiol 18(11S):S340\u2013S360. https:\/\/doi.org\/10.1016\/j.jacr.2021.08.003","journal-title":"J Am Coll Radiol"},{"key":"7974_CR64","doi-asserted-by":"publisher","unstructured":"Choufani M, Ghusn W, Dubreuil M, Ermann J (2025) Diversity in axial spondyloarthritis drug trials: enrollment by sex, race, ethnicity, and geographic region. J Rheumatol 52(12):1245\u20131253. https:\/\/doi.org\/10.3899\/jrheum.2024-1013","DOI":"10.3899\/jrheum.2024-1013"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07974-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:21:22Z","timestamp":1773217282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07974-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7974"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07974-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"C. Bakewell receives consulting and\/or speaker honoraria from AbbVie, Johnson & Johnson, Bristol Myers Squibb, Eli Lilly, Pfizer, UCB, Sanofi, and Novartis. A. Deodhar has advisory board memberships with Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, Novartis, and UCB, speaker engagements for Eli Lilly, Johnson & Johnson, Novartis, Pfizer, and UCB, and research grants from Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, MoonLake, Novartis, Pfizer, and UCB. G.C. Wright has served as a consultant for AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Fate Therapeutics, Johnson & Johnson, Eli Lilly, Novartis, Pfizer, Sanofi, Scipher Medicine, and UCB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}